A Systems View Across Time and Space
Table 7 Dynamic risk rates: rates that could be applied to the relevant stage being valued as a function of WACC and ROI (risk rates are indicated from their status in development to reimbursement)
New risk rate CVD by phase | ||
|---|---|---|
Status | CVD-specific phase rate | Endo/Meta-specific phase rate |
Pre ph III | 39.59 | 33.4 |
Pre ph I | 51.59 | 49.99 |
Pre ph I | 56.47 | 54.5 |
Discovery | 58.06 | 56.84 |